Jacob Fog Bentzon

Jacob Fog Bentzon

Auto-generated profile, based on publicly available information

Jacob Fog Bentzon

Aarhus University

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2014 in Circulation Research
Verified
Journal Article
Closed access
JBJacob Fog Bentzon
Jacob Fog Bentzon
FOFumiyuki Otsuka
Fumiyuki Otsuka
RVRenu Virmani
Renu Virmani
EFErling Falk
Erling Falk
Atherosclerosis causes clinical disease through luminal narrowing or by precipitating thrombi that obstruct blood flow to the heart (coronary heart disease), brain (ischemic stroke), or lower extremities (peripheral vascular disease). The most common of these manifestations is coronary heart disease, including stable angina pectoris and the acute coronary syndromes. Atherosclerosis is a lipoprotein-driven disease that leads to plaque formation at specific sites of the arterial tree through intimal inflammation, necrosis, fibrosis, and calcification. After decades of indolent progression, such plaques may suddenly cause life-threatening coronary thrombosis presenting as an acute coronary syndrome. Most often, the culprit morphology is plaque rupture with exposure of highly thrombogenic, red cell–rich necrotic core material. The permissive structural requirement for this to occur is an extremely thin fibrous cap, and thus, ruptures occur mainly among lesions defined as thin-cap fibroatheromas. Also common are thrombi forming on lesions without rupture (plaque erosion), most often on pathological intimal thickening or fibroatheromas. However, the mechanisms involved in plaque erosion remain largely unknown, although coronary spasm is suspected. The calcified nodule has been suggested as a rare cause of coronary thrombosis in highly calcified and tortious arteries in older individuals. To characterize the severity and prognosis of plaques, several terms are used. Plaque burden denotes the extent of disease, whereas plaque activity is an ambiguous term, which may refer to one of several processes that characterize progression. Plaque vulnerability describes the short-term risk of precipitating symptomatic thrombosis. In this review, we discuss mechanisms of atherosclerotic plaque initiation and progression; how plaques suddenly precipitate life-threatening thrombi; and the concepts of plaque burden, activity, and vulnerability.

13 February 2020 in European Heart Journal
Verified
Journal Article
Open access
JBJan Borén
Jan Borén
MCM John Chapman
M John Chapman
RKRonald M Krauss
Ronald M Krauss
CPChris J Packard
Chris J Packard
JBJacob F Bentzon
Jacob F Bentzon
HGHenry N Ginsberg
Henry N Ginsberg

13 December 2012 in European Heart Journal
Verified
Journal Article
Open access
PDF file
EFErling Falk
Erling Falk
MNMasataka Nakano
Masataka Nakano
JBJacob Fog Bentzon
Jacob Fog Bentzon
AFAloke V. Finn
Aloke V. Finn
RVRenu Virmani
Renu Virmani
Although mortality rates from coronary heart disease in the western countries have declined in the last few decades, morbidity caused by this disease is increasing and a substantial number of patients still suffer acute coronary syndrome (ACS) and sudden cardiac death. Acute coronary syndrome occurs as a result of myocardial ischaemia and its manifestations include acute myocardial infarction and unstable angina. Culprit plaque morphology in these patients varies from thrombosis with or without coronary occlusion to sudden narrowing of the lumen from intraplaque haemorrhage. The coronary artery plaque morphologies primarily responsible for thrombosis are plaque rupture, and plaque erosion, with plaque rupture being the most common cause of acute myocardial infarction, especially in men. Autopsy data demonstrate that women <50 years of age more frequently have erosion, whereas in older women, the frequency of rupture increases with each decade. Ruptured plaques are associated with positive (expansive) remodelling and characterized by a large necrotic core and a thin fibrous cap that is disrupted and infiltrated by foamy macrophages. Plaque erosion lesions are often negatively remodelled with the plaque itself being rich in smooth muscle cells and proteoglycans with minimal to absence of inflammation. Plaque haemorrhage may expand the plaque rapidly, leading to the development of unstable angina. Plaque haemorrhage may occur from plaque rupture (fissure) or from neovascularization (angiogenesis). Atherosclerosis is now recognized as an inflammatory disease with macrophages and T-lymphocytes playing a dominant role. Recently at least two subtypes of macrophages have been identified. M1 is a pro-inflammatory macrophage while M2 seems to play a role in dampening inflammation and promoting tissue repair. A third type of macrophage, termed by us as haemoglobin associated macrophage or M(Hb) which is observed at site of haemorrhage also can be demonstrated in human atherosclerosis. In order to further our understanding of the specific biological events which trigger plaque instability and as well as to monitor the effects of novel anti-atherosclerotic therapies newer imaging modalities in vivo are needed.

23 May 2014 in Circulation Research
Verified
Journal Article
Closed access
PDF file
MBMartin Mæng Bjørklund
Martin Mæng Bjørklund
AHAnne Kruse Hollensen
Anne Kruse Hollensen
MHMette Kallestrup Hagensen
Mette Kallestrup Hagensen
FDFrederik Dagnæs-Hansen
Frederik Dagnæs-Hansen
CCChristina Christoffersen
Christina Christoffersen
JBJacob Fog Bentzon
Jacob Fog Bentzon
Rationale:: Atherosclerosis can be achieved in animals by germline genetic engineering, leading to hypercholesterolemia, but such models are constrained to few species and strains, and they are difficult to combine with other powerful techniques involving genetic manipulation or variation. Objective:: To develop a method for induction of atherosclerosis without germline genetic engineering. Methods and Results:: Recombinant adeno-associated viral vectors were engineered to encode gain-of-function proprotein convertase subtilisin/kexin type 9 mutants, and mice were given a single intravenous vector injection followed by high-fat diet feeding. Plasma proprotein convertase subtilisin/kexin type 9 and total cholesterol increased rapidly and were maintained at high levels, and after 12 weeks, mice had atherosclerotic lesions in the aorta. Histology of the aortic root showed progression of lesions to the fibroatheromatous stage. To demonstrate the applicability of this method for rapid analysis of the atherosclerosis susceptibility of a mouse strain and for providing temporal control over disease induction, we demonstrated the accelerated atherosclerosis of mature diabetic Akita mice. Furthermore, the versatility of this approach for creating atherosclerosis models also in nonmurine species was demonstrated by inducing hypercholesterolemia and early atherosclerosis in Golden Syrian hamsters. Conclusions:: Single injections of proprotein convertase subtilisin/kexin type 9–encoding recombinant adeno-associated viral vectors are a rapid and versatile method to induce atherosclerosis in animals. This method should prove useful for experiments that are high-throughput or involve genetic techniques, strains, or species that do not combine well with current genetically engineered models.

1 December 2006 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
JBJacob F. Bentzon
Jacob F. Bentzon
CWCharlotte Weile
Charlotte Weile
CSClaus S. Sondergaard
Claus S. Sondergaard
JHJohnny Hindkjaer
Johnny Hindkjaer
MKMoustapha Kassem
Moustapha Kassem
EFErling Falk
Erling Falk
Objective— Recent studies of bone marrow (BM)-transplanted apoE knockout (apoE −/− ) mice have concluded that a substantial fraction of smooth muscle cells (SMCs) in atherosclerosis arise from circulating progenitor cells of hematopoietic origin. This pathway, however, remains controversial. In the present study, we reexamined the origin of plaque SMCs in apoE −/− mice by a series of BM transplantations and in a novel model of atherosclerosis induced in surgically transferred arterial segments. Methods and Results— We analyzed plaques in lethally irradiated apoE −/− mice reconstituted with sex-mismatched BM cells from eGFP + apoE −/− mice, which ubiquitously express enhanced green fluorescent protein (eGFP), but did not find a single SMC of donor BM origin among ≈10 000 SMC profiles analyzed. We then transplanted arterial segments between eGFP + apoE −/− and apoE −/− mice (isotransplantation except for the eGFP transgene) and induced atherosclerosis focally within the graft by a recently invented collar technique. No eGFP + SMCs were found in plaques that developed in apoE −/− artery segments grafted into eGFP + apoE −/− mice. Concordantly, 96% of SMCs were eGFP + in plaques induced in eGFP + apoE −/− artery segments grafted into apoE −/− mice. Conclusions— These experiments show that SMCs in atherosclerotic plaques are exclusively derived from the local vessel wall in apoE −/− mice.

2 January 2013 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
RARozh Al-Mashhadi
Rozh Al-Mashhadi
CSCharlotte B. Sørensen
Charlotte B. Sørensen
PKPeter M. Kragh
Peter M. Kragh
CCChristina Christoffersen
Christina Christoffersen
MMMartin B. Mortensen
Martin B. Mortensen
JBJacob F. Bentzon
Jacob F. Bentzon
Lack of animal models with human-like size and pathology hampers translational research in atherosclerosis. Mouse models are missing central features of human atherosclerosis and are too small for intravascular procedures and imaging. Modeling the disease in minipigs may overcome these limitations, but it has proven difficult to induce rapid atherosclerosis in normal pigs by high-fat feeding alone, and genetically modified models similar to those created in mice are not available. D374Y gain-of-function mutations in the proprotein convertase subtilisin/kexin type 9 (PCSK9) gene cause severe autosomal dominant hypercholesterolemia and accelerates atherosclerosis in humans. Using Sleeping Beauty DNA transposition and cloning by somatic cell nuclear transfer, we created Yucatan minipigs with liver-specific expression of human D374Y-PCSK9. D374Y-PCSK9 transgenic pigs displayed reduced hepatic low-density lipoprotein (LDL) receptor levels, impaired LDL clearance, severe hypercholesterolemia, and spontaneous development of progressive atherosclerotic lesions that could be visualized by noninvasive imaging. This model should prove useful for several types of translational research in atherosclerosis.